Cold Atmospheric Plasma Treatment and Surgical Site Infections
Standard
Cold Atmospheric Plasma Treatment and Surgical Site Infections. / Rutkowski, Rico; Thom, Vu Thi ; Dinh Minh, Nguyen ; Metelmann, Hans-Robert.
Textbook of Good Clinical Practice in Cold Plasma Therapy. Hrsg. / Hans-Robert Metelmann; Thomas von Woedtke; Klaus-Dieter Weltmann; Steffen Emmert. 1. Aufl. Springer Nature Switzerland AG, 2022. S. 199-212.Publikationen: SCORING: Beitrag in Buch/Sammelwerk › Kapitel › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - CHAP
T1 - Cold Atmospheric Plasma Treatment and Surgical Site Infections
AU - Rutkowski, Rico
AU - Thom, Vu Thi
AU - Dinh Minh, Nguyen
AU - Metelmann, Hans-Robert
PY - 2022/2/28
Y1 - 2022/2/28
N2 - Based on an increasing understanding of the cellular and molecular effects, the clinical use of cold atmospheric plasma is constantly expanding. Surgical site infections (SSI), which are a considerable burden to both individual patients and public health system, thus appear to be a promising indication for this innovative technology. In particular, the field of antimicrobial efficacy can reference to in vivo and in vitro assured treatment success, opening up interdisciplinary approaches and potentials. While the typical causal pathogen spectrum depends on the type of surgery, several endogenous and exogenous risk factors have been identified. The chapter provides an overview of how cold atmospheric plasma could enhance existing anti-SSI prevention and therapy concepts. While there is still a need for further evidence-based research the interim evaluation demonstrates the comprehensive potential of cold atmospheric plasma in the fight against this type of healthcare-associated nosocomial infection including all medical and economic challenges.
AB - Based on an increasing understanding of the cellular and molecular effects, the clinical use of cold atmospheric plasma is constantly expanding. Surgical site infections (SSI), which are a considerable burden to both individual patients and public health system, thus appear to be a promising indication for this innovative technology. In particular, the field of antimicrobial efficacy can reference to in vivo and in vitro assured treatment success, opening up interdisciplinary approaches and potentials. While the typical causal pathogen spectrum depends on the type of surgery, several endogenous and exogenous risk factors have been identified. The chapter provides an overview of how cold atmospheric plasma could enhance existing anti-SSI prevention and therapy concepts. While there is still a need for further evidence-based research the interim evaluation demonstrates the comprehensive potential of cold atmospheric plasma in the fight against this type of healthcare-associated nosocomial infection including all medical and economic challenges.
U2 - 10.1007/978-3-030-87857-3
DO - 10.1007/978-3-030-87857-3
M3 - Chapter
SN - 978-3-030-87856-6
SP - 199
EP - 212
BT - Textbook of Good Clinical Practice in Cold Plasma Therapy
A2 - Metelmann, Hans-Robert
A2 - von Woedtke, Thomas
A2 - Weltmann, Klaus-Dieter
A2 - Emmert, Steffen
PB - Springer Nature Switzerland AG
ER -